Stem Cell Research
Cardiogenesis Submits IDE to Initiate a Clinical Trial for Its PHOENIX Combination Delivery System
Published in Hematology Week, January 11th, 2010
Cardiogenesis Corporation (Pink Sheets: CGCP), announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.
Dr. Guillermo Reyes, Department of Cardiovascular Surgery, Hospital Universitario La Princesa, Madrid, Spain commented on his preliminary clinical experience with the device. "To date I have successfully treated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2010-01-11)
More Articles from Hematology Week
- American Associates, Ben-Gurion University of the Negev
Anti-inflammatory drugs coxibs interfere with aspirin's clotting ability -- Ben-Gurion U. - NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Blood stem cell transplant regimen reverses sickle cell disease in adults - University of Georgia
Study finds significantly worse outcomes in cancer patients with cognitive impairment - University of Iowa
Study shows a key protein helps control blood pressure - Antibiotics
Researchers from Hadassah University report details of new studies and findings in the area of antibiotics - Candidiasis
New candidiasis research from P.E. Charles et al outlined - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
